Complement in therapy and disease Regulating the complement system with antibody-based therapeutics

被引：108
作者：
Melis, Joost P. M. [1 ]
Strumane, Kristin [1 ]
Ruuls, Sigrid R. [1 ]
Beurskens, Frank J. [1 ]
Schuurman, Janine [1 ]
Parren, Paul W. H. I. [1 ,2 ]
机构：
[1] Genmab, NL-3584 CM Utrecht, Netherlands
[2] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands
来源：
MOLECULAR IMMUNOLOGY | 2015年 / 67卷 / 02期
关键词：
Complement; Immunology; Antibody; Therapy; Antibody engineering; Cancer; ANTI-CD20; MONOCLONAL-ANTIBODY; LYMPHOCYTIC-LEUKEMIA CELLS; HEMOLYTIC-UREMIC SYNDROME; FACTOR-H POLYMORPHISM; IGG FC-RECEPTOR; DEPENDENT CYTOTOXICITY; EFFECTOR FUNCTIONS; STAPHYLOCOCCUS-AUREUS; SEGMENTAL FLEXIBILITY; MEDIATED LYSIS;
D O I：
10.1016/j.molimm.2015.01.028
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Complement is recognized as a key player in a wide range of normal as well as disease-related immune, developmental and homeostatic processes. Knowledge of complement components, structures, interactions, and cross-talk with other biological systems continues to grow and this leads to novel treatments for cancer, infectious, autoimmune- or age-related diseases as well as for preventing transplantation rejection. Antibodies are superbly suited to be developed into therapeutics with appropriate complement stimulatory or inhibitory activity. Here we review the design, development and future of antibody-based drugs that enhance or dampen the complement system. (C) 2015 The Authors. Published by Elsevier Ltd.
引用
收藏
页码：117 / 130
页数：14
相关论文
共 206 条
[1]   Clinical Relevance of Pretransplant Donor-Specific HLA Antibodies Detected by Single-Antigen Flow-Beads [J].
Amico, Patrizia ;
Hoenger, Gideon ;
Mayr, Michael ;
Steiger, Juerg ;
Hopfer, Helmut ;
Schaub, Stefan .
TRANSPLANTATION, 2009, 87 (11) :1681-1688
[2]   Extensive restrictions in the VH sequence usage of the human antibody response against the Rhesus D antigen [J].
Andersen, Peter S. ;
Haahr-Hansen, Margit ;
Coljee, Vincent W. ;
Hinnerfeldt, Frank R. ;
Varming, Kim ;
Bregenholt, Soren ;
Haurum, John S. .
MOLECULAR IMMUNOLOGY, 2007, 44 (04) :412-422
[3]   Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma [J].
Anderson, DR ;
GrilloLopez, A ;
Varns, C ;
Chambers, KS ;
Hanna, N .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) :705-708
[4]   Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration [J].
Ansari, Morad ;
Mckeigue, Paul M. ;
Skerka, Christine ;
Hayward, Caroline ;
Rudan, Igor ;
Vitart, Veronique ;
Polasek, Ozren ;
Armbrecht, Ana-Maria ;
Yates, John R. W. ;
Vatavuk, Zoran ;
Bencic, Goran ;
Kolcic, Ivana ;
Oostra, Ben A. ;
Van Duijn, Cornelia M. ;
Campbell, Susan ;
Stanton, Chloe M. ;
Huffman, Jennifer ;
Shu, Xinhua ;
Khan, Jane C. ;
Shahid, Humma ;
Harding, Simon P. ;
Bishop, Paul N. ;
Deary, Ian J. ;
Moore, Anthony T. ;
Dhillon, Baljean ;
Rudan, Pavao ;
Zipfel, Peter F. ;
Sim, Robert B. ;
Hastie, Nicholas D. ;
Campbell, Harry ;
Wright, Alan F. .
HUMAN MOLECULAR GENETICS, 2013, 22 (23) :4857-4869
[5]   Human serum IgM glycosylation - Identification of glycoforms that can bind to mannan-binding lectin [J].
Arnold, JN ;
Wormald, MR ;
Suter, DM ;
Radcliffe, CM ;
Harvey, DJ ;
Dwek, RA ;
Rudd, PM ;
Sim, RB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (32) :29080-29087
[6]   Induced Resistance to Ofatumumab-Mediated Cell Clearance Mechanisms, Including Complement-Dependent Cytotoxicity, in Chronic Lymphocytic Leukemia [J].
Baig, Nisar A. ;
Taylor, Ronald P. ;
Lindorfer, Margaret A. ;
Church, Amy K. ;
LaPlant, Betsy R. ;
Pettinger, Adam M. ;
Shanafelt, Tait D. ;
Nowakowski, Grzegorz S. ;
Zent, Clive S. .
JOURNAL OF IMMUNOLOGY, 2014, 192 (04) :1620-1629
[7]   Complement and autoimmunity [J].
Ballanti, Eleonora ;
Perricone, Carlo ;
Greco, Elisabetta ;
Ballanti, Marta ;
Di Muzio, Gioia ;
Chimenti, Maria Sole ;
Perricone, Roberto .
IMMUNOLOGIC RESEARCH, 2013, 56 (2-3) :477-491
[8]   Role of C3a Receptors, C5a Receptors, and Complement Protein C6 Deficiency in Collagen Antibody-Induced Arthritis in Mice [J].
Banda, Nirmal K. ;
Hyatt, Stephanie ;
Antonioli, Alexandra H. ;
White, Jason T. ;
Glogowska, Magdalena ;
Takahashi, Kazue ;
Merkel, Tod J. ;
Stahl, Gregory L. ;
Mueller-Ortiz, Stacey ;
Wetsel, Rick ;
Arend, William P. ;
Holers, V. Michael .
JOURNAL OF IMMUNOLOGY, 2012, 188 (03) :1469-1478
[9]   Targeting the complement system in systemic lupus erythematosus and other diseases [J].
Barilla-LaBarca, Maria-Louise ;
Toder, Kiley ;
Furie, Richard .
CLINICAL IMMUNOLOGY, 2013, 148 (03) :313-321
[10]   Ofatumumab demonstrates activity against rituximab-sensitive and -resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B-cell lymphoma [J].
Barth, Matthew J. ;
Hernandez-Ilizaliturri, Francisco J. ;
Mavis, Cory ;
Tsai, Ping-Chiao ;
Gibbs, John F. ;
Deeb, George ;
Czuczman, Myron S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (04) :490-498
12345678910